Venus Concept secures additional $2 million in bridge financing

Venus Concept Inc. (NASDAQ:VERO), a medical technology company with a market capitalization of $4.8 million and trailing twelve-month revenue of $60.11 million, received an additional $2 million in bridge financing under its existing loan and security agreement, according to a statement released in a Securities and Exchange Commission filing. According to InvestingPro analysis, the company currently shows a Weak financial health score, with declining revenue growth of -13.9% over the past year.

On Thursday, the company and its subsidiaries obtained the eleventh drawdown under the agreement with lenders Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP. The loan bears interest at 12% per annum and is secured by a priority security interest in all real and personal property collateral of the company and its subsidiaries. The company’s total debt stands at $37.06 million, with a current ratio of 1.1, indicating tight liquidity conditions.

The proceeds from the latest drawdown are expected to be used for general working capital purposes, after payment of transaction expenses.

This financing is part of a broader bridge financing agreement, originally entered on April 23, 2024, which has been amended to increase the total available principal from $5 million to approximately $23.2 million. Since the initial drawdown in April 2024, Venus Concept has received a series of subsequent loans, with the eleventh drawdown funded on Thursday.

Under the terms of the agreement, all unpaid principal and accrued interest are due on the maturity date of the bridge financing.

This information is based on a statement included in a press release filed with the Securities and Exchange Commission.

In other recent news, Venus Concept Inc reported a 5% year-over-year decline in revenue for the second quarter of 2025, bringing in $15.7 million. The company also experienced a net loss of $11.7 million, or $8.03 per share, along with an adjusted EBITDA loss of $8.8 million. Despite these financial setbacks, Venus Concept is concentrating on strategic initiatives, including a planned product launch set for early 2026. The company is also exploring opportunities in the weight loss market. However, Venus Concept has not provided full-year guidance for 2025. These developments highlight the company’s current focus and future plans amid financial challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.